TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT04671771: A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

Sponsor: W.L.Gore & Associates · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 133 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$2,556,400

Rescue Site Savings

+$1,693,200

Unlock Full NCT04671771 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT04671771 Rescue Dossier →